ADMA BIOLOGICS, INC. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Adma Biologics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2019 to Q3 2024.
  • Adma Biologics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $8.9M, a 8.78% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $8.9M -$857K -8.78% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $9.15M -$852K -8.52% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $9.4M -$851K -8.3% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $9.64M -$850K -8.11% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 $9.75M -$582K -5.63% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $10M -$546K -5.18% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $10.2M +$3.14M +44.2% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $10.5M +$3.22M +44.4% Dec 31, 2022 10-K 2024-02-28
Q3 2022 $10.3M +$3.64M +54.5% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $10.6M +$3.72M +54.5% Jun 30, 2022 10-Q 2022-08-10
Q1 2022 $7.11M +$909K +14.7% Mar 31, 2022 10-Q 2022-05-11
Q4 2021 $7.26M +$3M +70.5% Dec 31, 2021 10-K 2023-03-23
Q3 2021 $6.69M +$3.91M +140% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $6.83M +$5.13M +302% Jun 30, 2021 10-Q 2021-08-11
Q1 2021 $6.2M Mar 31, 2021 10-Q 2021-05-12
Q4 2020 $4.26M +$3.01M +242% Dec 31, 2020 10-K 2022-03-24
Q3 2020 $2.78M Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $1.7M Jun 30, 2020 10-Q 2020-08-05
Q4 2019 $1.25M Dec 31, 2019 10-K 2021-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.